Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on Invested CapitalReturn on Sales

Dr Reddys Laboratories (RDY) Return on Sales (2016 - 2025)

Historic Return on Sales for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to 0.14%.

  • Dr Reddys Laboratories' Return on Sales fell 300.0% to 0.14% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.11%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.18% for FY2025, which is 200.0% down from last year.
  • Latest data reveals that Dr Reddys Laboratories reported Return on Sales of 0.14% as of Q4 2025, which was down 300.0% from 4.66% recorded in Q3 2025.
  • Dr Reddys Laboratories' Return on Sales' 5-year high stood at 0.23% during Q1 2022, with a 5-year trough of 4.66% in Q3 2025.
  • Moreover, its 5-year median value for Return on Sales was 0.18% (2024), whereas its average is 0.08%.
  • In the last 5 years, Dr Reddys Laboratories' Return on Sales soared by 2200bps in 2023 and then plummeted by -48300bps in 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Return on Sales (Quarter) stood at 0.02% in 2021, then skyrocketed by 853bps to 0.15% in 2022, then grew by 29bps to 0.2% in 2023, then dropped by -14bps to 0.17% in 2024, then dropped by -19bps to 0.14% in 2025.
  • Its last three reported values are 0.14% in Q4 2025, 4.66% for Q3 2025, and 0.18% during Q2 2025.